Live Breaking News & Updates on Chembio Diagnostics Inc

Stay updated with breaking news from Chembio diagnostics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Chembio Diagnostics (NASDAQ:CEMI) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report report published on Tuesday. The firm issued a hold rating on the stock. Chembio Diagnostics Stock Performance Shares of CEMI opened at $0.46 on Tuesday. The stock has a 50-day moving average of $0.43 and a two-hundred day moving […] ....

Chembio Diagnostics Inc , Renaissance Technologies , Securities Exchange Commission , Virtu Financial , Vanguard Group Inc , Chembio Diagnostics , Get Rating , Advisors Ll Perceptive , Exchange Commission , Chembio Diagnostics Daily , Nasdaq Cemi , Initiated Coverage , Stocknews Com ,

Ace Cash Achieves Self Reported Market Cap of $49.69 Million (ACEC)

Chembio Diagnostics, Inc. (NASDAQ:CEMI – Get Rating) shares crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.36 and traded as high as $0.46. Chembio Diagnostics shares last traded at $0.46, with a volume of 351,600 shares changing hands. Analyst Upgrades […] ....

Chembio Diagnostics Inc , Virtu Financial , Chembio Diagnostics Company Profile , Renaissance Technologies , York Mellon Corp , Chembio Diagnostics , Get Rating , Advisors Ll Perceptive , New York Mellon Corp , Chembio Diagnostics Daily ,

Chembio Diagnostics (NASDAQ:CEMI) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a report issued on Sunday. The firm issued a hold rating on the stock. Chembio Diagnostics Stock Performance The firm’s 50 day moving average is $0.43 and its two-hundred day moving average is $0.36. Chembio Diagnostics has a fifty-two week low of […] ....

York Mellon Corp , Vanguard Group Inc , Renaissance Technologies , Securities Exchange Commission , Virtu Financial , Chembio Diagnostics Inc , Chembio Diagnostics , Get Rating , Advisors Ll Perceptive , Exchange Commission , New York Mellon Corp , Chembio Diagnostics Daily , Nasdaq Cemi , Initiated Coverage , Stocknews Com ,

Chembio Diagnostics (NASDAQ:CEMI) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Chembio Diagnostics (NASDAQ:CEMI – Get Rating) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the stock. Chembio Diagnostics Trading Up 0.2 % CEMI opened at $0.46 on Friday. Chembio Diagnostics has a 12-month low of […] ....

York Mellon Corp , Vanguard Group Inc , Renaissance Technologies , Chembio Diagnostics Inc , Virtu Financial , Chembio Diagnostics , Get Rating , Advisors Ll Perceptive , New York Mellon Corp , Chembio Diagnostics Daily , Nasdaq Cemi , Initiated Coverage , Stocknews Com ,

Sale of test maker Chembio clears bar for shareholder approval on fourth try

The company, which has facilities in Medford and Bay Shore, manufactures rapid diagnostic tests for infectious diseases such as HIV, malaria, COVID-19 and Ebola. ....

United States , Jamest Madore , Larry Abensur , Us Food Drug Administration , Chembio Diagnostics Inc , Chembio Diagnostics , Bay Shore , Drug Administration , Emergency Use Authorization ,